Actively Recruiting
Study of Immediate Lymphatic Reconstruction During Lymph Node Removal Surgery in Adults with Melanoma to Prevent Lymphedema
Led by M.D. Anderson Cancer Center · Updated on 2026-06-18
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether performing lymphovenous bypass LVB at the time of lymph node removal surgery can help prevent lymphedema in melanoma patients. The study aims to see if LVB done during axillary or inguinal lymph node dissection reduces the occurrence of lymphedema over a year compared to when it is done after lymphedema develops. It also evaluates wound complications within 30 days post-surgery and quality of life related to lymphedema. Participants will undergo LVB during their scheduled lymph node dissection surgery, either axillary lymph node dissection ALND or inguinal lymph node dissection ILND. The study includes two groups based on surgery location one group receiving ALND and the other ILND, both receiving the LVB procedure at surgery time. Participants are recruited before surgery by their treating physicians. During the study, participants will be monitored for safety and adverse events for about one year. Researchers will track the time until surgical drains are removed, assess lymphedema presence at 3, 6, and 12 months after surgery, and evaluate quality of life using the Lymphedema Quality of Life questionnaire. This follow-up helps understand the impact of the procedure on lymphedema prevention and patient well-being.
CONDITIONS
Brief Title
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
Research Team
A
Ashleigh M Francis, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here